These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 23763529)

  • 1. Economic evaluations of point of care testing strategies for active tuberculosis.
    Zwerling A; Dowdy D
    Expert Rev Pharmacoecon Outcomes Res; 2013 Jun; 13(3):313-25. PubMed ID: 23763529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A modelling framework to support the selection and implementation of new tuberculosis diagnostic tools.
    Lin HH; Langley I; Mwenda R; Doulla B; Egwaga S; Millington KA; Mann GH; Murray M; Squire SB; Cohen T
    Int J Tuberc Lung Dis; 2011 Aug; 15(8):996-1004. PubMed ID: 21740663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Point-of-care diagnostics for HIV and tuberculosis: landscape, pipeline, and unmet needs.
    Pai NP; Pai M
    Discov Med; 2012 Jan; 13(68):35-45. PubMed ID: 22284782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of Rapid, Point-of-Care Assays by Private Practitioners in Chennai, India: Priorities for Tuberculosis Diagnostic Testing.
    Bronner Murrison L; Ananthakrishnan R; Sukumar S; Augustine S; Krishnan N; Pai M; Dowdy DW
    PLoS One; 2016; 11(6):e0155775. PubMed ID: 27304061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Public health costs for tuberculosis suspects in Wake County, North Carolina, United States.
    Park PH; Holland DP; Wade A; Goswami ND; Bissette D; Stout JE
    Int J Tuberc Lung Dis; 2013 Jun; 17(6):759-63. PubMed ID: 23676158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-Effectiveness of POC Coagulation Testing Using Multiple Electrode Aggregometry.
    Straub N; Bauer E; Agarwal S; Meybohm P; Zacharowski K; Hanke AA; Weber CF
    Clin Lab; 2016; 62(6):1167-78. PubMed ID: 27468580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic evaluation of point-of-care diagnostic technologies for infectious diseases.
    Loubiere S; Moatti JP
    Clin Microbiol Infect; 2010 Aug; 16(8):1070-6. PubMed ID: 20670289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic considerations of point-of-care testing.
    Keffer JH
    Am J Clin Pathol; 1995 Oct; 104(4 Suppl 1):S107-10. PubMed ID: 7484941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The societal cost of tuberculosis: Tarrant County, Texas, 2002.
    Miller TL; McNabb SJ; Hilsenrath P; Pasipanodya J; Drewyer G; Weis SE
    Ann Epidemiol; 2010 Jan; 20(1):1-7. PubMed ID: 20006270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of a dual non-treponemal/treponemal syphilis point-of-care test to prevent adverse pregnancy outcomes in sub-Saharan Africa.
    Owusu-Edusei K; Gift TL; Ballard RC
    Sex Transm Dis; 2011 Nov; 38(11):997-1003. PubMed ID: 21992974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guidelines for point-of-care testing. Improving patient outcomes.
    Kost GJ
    Am J Clin Pathol; 1995 Oct; 104(4 Suppl 1):S111-27. PubMed ID: 7484942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost analysis of paediatric tuberculosis treatment in Japan.
    Rahman M; Takahashi O; Takamatsu I; Sekimoto M; Hira K; Fukui T
    Int J Tuberc Lung Dis; 2003 Mar; 7(3):254-7. PubMed ID: 12661840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic pain: reducing costs through early implementation of adherence testing and recognition of opioid misuse.
    McCarberg BH
    Postgrad Med; 2011 Nov; 123(6):132-9. PubMed ID: 22104462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TB diagnostic tests: how do we figure out their costs?
    Sohn H; Minion J; Albert H; Dheda K; Pai M
    Expert Rev Anti Infect Ther; 2009 Aug; 7(6):723-33. PubMed ID: 19681700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Model-based economic evaluations of diagnostic point of care tests were rarely fit for purpose.
    Breheny K; Sutton AJ; Deeks JJ
    J Clin Epidemiol; 2019 May; 109():1-11. PubMed ID: 30423377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beyond accuracy: creating a comprehensive evidence base for TB diagnostic tools.
    Mann G; Squire SB; Bissell K; Eliseev P; Du Toit E; Hesseling A; Nicol M; Detjen A; Kritski A
    Int J Tuberc Lung Dis; 2010 Dec; 14(12):1518-24. PubMed ID: 21144235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Point-of-care diagnosis of tuberculosis: past, present and future.
    Dheda K; Ruhwald M; Theron G; Peter J; Yam WC
    Respirology; 2013 Feb; 18(2):217-32. PubMed ID: 23190246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different challenges, different approaches and related expenditures of community-based tuberculosis activities by international non-governmental organizations in Myanmar.
    Han WW; Saw S; Isaakidis P; Khogali M; Reid A; Hoa N; Zaw KK; Aung ST
    Infect Dis Poverty; 2017 Mar; 6(1):59. PubMed ID: 28335801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of novel diagnostic tools for the diagnosis of tuberculosis.
    Dowdy DW; O'Brien MA; Bishai D
    Int J Tuberc Lung Dis; 2008 Sep; 12(9):1021-9. PubMed ID: 18713499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tuberculosis diagnostics: test developers' FAQs.
    Pai M
    Int J Tuberc Lung Dis; 2013 May; 17(5):570-1. PubMed ID: 23575319
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.